MedTrace Logo

Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19

NCT04632082 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2200

Last updated 2020-11-20

No results posted yet for this study

Summary

A pragmatic superiority randomized controlled trial comparing Telepsychoeducation plus personalized videos vs. Telepsychoeducation without personalized videos for the prevention of future emotional distress in professionals and students from essential services with low to moderate levels of emotional distress in Brazil.

Note: This study was approved by the Ethics and Research Committee of the Hospital de Clínicas de Porto Alegre and is originally registered at Plataforma Brasil, a Brazilian study registration platform (under CAAE: 30608420.5.0000.5327). Recruitment began in May 28th 2020.

Conditions

  • Mental Health Wellness 1
  • COVID
  • Emotional Distress
  • Depressive Symptoms
  • Anxiety Symptoms
  • Irritability
  • Telepsychotherapy

Interventions

BEHAVIORAL

Telepsychoeducation with personalized videos

1 session with a psychologist plus 1 video a week for 4 weeks chosen based on symptom presentation

BEHAVIORAL

Telepsychoeducation without personalized videos

1 session with a psychologist focused on reassurance and aspects of the outbreak

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Giovanni Salum, MD, PhD · Hospital de Clínicas de Porto Alegre, Porto Alegre/Brazil

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-05
Primary Completion
2021-07-13
Completion
2021-07-20

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04632082 on ClinicalTrials.gov